(Q40888785)

24 September 2017

1 reference

title

Drug administration in chronic liver disease (English)

1 reference

24 September 2017

main subject

chronic liver disease

0 references

author name string

J F Westphal

series ordinal

1

1 reference

24 September 2017

J M Brogard

series ordinal

2

1 reference

24 September 2017

publication date

1 July 1997

1 reference

24 September 2017

1 reference

24 September 2017

volume

17

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

47-73

1 reference

Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function

24 September 2017

cites work

1 reference

12 December 2020

Furosemide absorption in patients with cirrhosis.

1 reference

12 December 2020

Effect of liver function on the metabolism of prednisone and prednisolone in humans

1 reference

12 December 2020

Triamterene kinetics and dynamics in cirrhosis

1 reference

12 December 2020

Pharmacokinetics of zidovudine in patients with liver cirrhosis

1 reference

12 December 2020

Effects of captopril on renal function in patients with cirrhosis and ascites

1 reference

12 December 2020

Successful administration of metoclopramide for the treatment of nausea in patients with advanced liver disease. A double-blind controlled trial

1 reference

12 December 2020

Single-dose and steady-state pharmacokinetics of fosinopril and fosinoprilat in patients with hepatic impairment

1 reference

12 December 2020

Letter: Subacute and chronic active hepatitis after withdrawal of chemotherapy

1 reference

12 December 2020

Propranolol in psychiatry. Therapeutic uses and side effects

1 reference

12 December 2020

Dose-dependent pharmacokinetics of caffeine in humans: relevance as a test of quantitative liver function

1 reference

12 December 2020

Quinidine pharmacokinetics in patients with cirrhosis or receiving propranolol

1 reference

12 December 2020

Chlordiazepoxide and oxazepam disposition in cirrhosis

1 reference

12 December 2020

Pharmacokinetics of metoclopramide in patients with liver cirrhosis.

1 reference

12 December 2020

The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites

1 reference

12 December 2020

Disposition of a flow-limited drug (lidocaine) and a metabolic capacity-limited drug (theophylline) in liver cirrhosis.

1 reference

12 December 2020

Pharmacokinetics of theophylline in hepatic disease

1 reference

12 December 2020

Fulminant hepatic failure in nephrotic syndrome related to withdrawal of immunosuppressive therapy

1 reference

12 December 2020

Pharmacokinetics of ornidazole in patients with acute viral hepatitis, alcoholic cirrhosis, and extrahepatic cholestasis

1 reference

12 December 2020

Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics

1 reference

12 December 2020

Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system

1 reference

12 December 2020

Compartmentalization of Ascites and Edema in Patients with Hepatic Cirrhosis

1 reference

12 December 2020

Clinical relevance of cimetidine drug interactions

1 reference

12 December 2020

Mechanism of the inhibition of the gamma-carboxylation of glutamic acid by N-methylthiotetrazole-containing antibiotics

1 reference

12 December 2020

Beta-Lactam antibiotic-induced leukopenia in severe hepatic dysfunction: risk factors and implications for dosing in patients with liver disease

1 reference

12 December 2020

Clinical pharmacokinetics of alprazolam. Therapeutic implications

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of nitrendipine in healthy subjects and patients with kidney and liver disease

1 reference

12 December 2020

Plasma Disappearance and Cerebral Effects of Chlorpromazine in Cirrhosis

1 reference

12 December 2020

Precipitation of hepatic encephalopathy by propranolol in cirrhosis

1 reference

12 December 2020

Grand mal seizures as a complication of treatment with pefloxacin in patients with cirrhosis. A report of three cases.

1 reference

12 December 2020

Effect of liver failure on the pharmacokinetics of cyclophosphamide

1 reference

12 December 2020

Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial

1 reference

12 December 2020

Pharmacokinetics of flecainide in patients with cirrhosis of the liver

1 reference

12 December 2020

Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis

1 reference

12 December 2020

Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease

1 reference

12 December 2020

Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences

1 reference

12 December 2020

Pharmacokinetics of famotidine in patients with cirrhosis and ascites

1 reference

12 December 2020

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

1 reference

12 December 2020

Digitoxin and its metabolites in patients with liver cirrhosis

1 reference

12 December 2020

Pharmacokinetics and haemodynamic effects of a single oral dose of the novel ACE inhibitor spirapril in patients with chronic liver disease

1 reference

12 December 2020

Effects of hydration on gentamicin excretion and renal accumulation in furosemide-treated rats

1 reference

12 December 2020

Renal Kallikrein Excretion in Cirrhotics with Ascites: Relationship to Renal Hemodynamics

1 reference

12 December 2020

Mezlocillin kinetics in hepatic insufficiency

1 reference

12 December 2020

Effect of hepatic dysfunction on oral cyclosporin pharmacokinetics in marrow transplant patients

1 reference

12 December 2020

Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B

1 reference

12 December 2020

Cimetidine spares the glucuronidation of lorazepam and oxazepam

1 reference

12 December 2020

The influence of hepatic cirrhosis on the pharmacokinetics of benazepril hydrochloride

1 reference

12 December 2020

Hepatic extraction of morphine is impaired in cirrhosis

1 reference

12 December 2020

Omeprazole. Overview and opinion

1 reference

12 December 2020

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man.

1 reference

12 December 2020

Risk Factors for Nephrotoxicity in Patients Treated with Aminoglycosides

1 reference

12 December 2020

Kinetics and dynamics of enalapril in patients with liver cirrhosis

1 reference

12 December 2020

Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure

1 reference

12 December 2020

Profile of etodolac: pharmacokinetic evaluation in special populations

1 reference

12 December 2020

Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy

1 reference

12 December 2020

Side effects of alpha interferon

1 reference

12 December 2020

Structure-activity and structure-side-effect relationships for the quinolone antibacterials

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis

1 reference

12 December 2020

Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study

1 reference

12 December 2020

Changes in the Status of Neurotransmitter Receptors in a Rabbit Model of Hepatic Encephalopathy

1 reference

12 December 2020

Ranitidine disposition and systemic availability in hepatic cirrhosis

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of the diuretic bumetanide in hepatic and renal disease

1 reference

12 December 2020

Effects of aging and liver disease on disposition of lorazepam

1 reference

12 December 2020

Nephrotoxicity of vancomycin, alone and with an aminoglycoside

1 reference

12 December 2020

A randomized comparison of metoclopramide and domperidone on plasma aldosterone concentration and on spironolactone-induced diuresis in ascitic cirrhotic patients.

1 reference

12 December 2020

Stimulation of drug metabolism by rifampicin in patients with cirrhosis or cholestasis measured by increased hexobarbital and tolbutamide clearance

1 reference

12 December 2020

Pharmacokinetics of famciclovir in subjects with chronic hepatic disease

1 reference

12 December 2020

Isoniazid prophylaxis in hepatitis B carriers

1 reference

12 December 2020

Hepatic encephalopathy and altered cimetidine kinetics

1 reference

12 December 2020

Gastrointestinal bleeding after abrupt cessation of propranolol administration in cirrhosis

1 reference

12 December 2020

Inhibition by fluoxetine of cytochrome P450 2D6 activity.

1 reference

12 December 2020

Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide

1 reference

12 December 2020

Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier

1 reference

12 December 2020

Rifampin-isoniazid therapy of alcoholic and nonalcoholic tuberculous patients in a U.S. Public Health Service Cooperative Therapy Trial

1 reference

12 December 2020

Adverse Effects of Monobactams and Carbapenems

1 reference

12 December 2020

Pharmacokinetics of the novel antiestrogenic agent toremifene in subjects with altered liver and kidney function.

1 reference

12 December 2020

The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration

1 reference

12 December 2020

Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus

1 reference

12 December 2020

Aminoglycoside nephrotoxicity

1 reference

12 December 2020

Fleroxacin pharmacokinetics in patients with liver cirrhosis

1 reference

12 December 2020

Changes in the clearance of total and unbound etoposide in patients with liver dysfunction

1 reference

12 December 2020

Single-dose pharmacokinetics of fluconazole in patients with liver cirrhosis

1 reference

12 December 2020

Cirrhosis of the liver markedly impairs the elimination of mexiletine

1 reference

12 December 2020

An intensive drug monitoring study suggesting possible clinical irrelevance of impaired drug disposition in liver disease

1 reference

12 December 2020

Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.

1 reference

12 December 2020

Multiple-dose pharmacokinetics of pefloxacin in patients with hepatocellular deficiency

1 reference

12 December 2020

Pharmacokinetics of methylprednisolone hemisuccinate and methylprednisolone in chronic liver disease

1 reference

12 December 2020

Safety perspectives on parenteral H2-receptor antagonists

1 reference

12 December 2020

Isoniazid-rifampin-induced hepatitis in hepatitis B carriers

1 reference

12 December 2020

The effect of liver disease in man on the disposition of phenobarbital

1 reference

12 December 2020

Is aldosterone secretion under dopaminergic control?

1 reference

12 December 2020

Fluoxetine disposition and elimination in cirrhosis

1 reference

12 December 2020

Influence of acute viral hepatitis on phenytoin kinetics and protein binding

1 reference

12 December 2020

Isolation of human hepatic microsomes and their inhibition by cimetidine and ranitidine

1 reference

12 December 2020

Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis

1 reference

12 December 2020

Acquired Vitamin K-Dependent Carboxylation Deficiency in Liver Disease

1 reference

12 December 2020

Lidocaine Pharmacokinetics in Advanced Heart Failure, Liver Disease, and Renal Failure in Humans

1 reference

12 December 2020

[14C]aminopyrine breath analysis and conventional biochemical tests as predictors of survival in cirrhosis

1 reference

12 December 2020

Ibuprofen and sulindac kinetics in alcoholic liver disease

1 reference

12 December 2020

Nonoliguric acute renal failure after captopril therapy

1 reference

12 December 2020

Conjugation pathways in liver disease

1 reference

12 December 2020

Once-daily aminoglycoside therapy

1 reference

12 December 2020

A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report

1 reference

12 December 2020

Clinical pharmacology of loop diuretics in health and disease

1 reference

12 December 2020

Pharmacokinetics of famotidine after intravenous administration in liver disease

1 reference

12 December 2020

Both phenolic and acyl glucuronidation pathways of diflunisal are impaired in liver cirrhosis

1 reference

12 December 2020

Specific toxicologic aspects of the quinolones.

1 reference

12 December 2020

Effect of captopril on renin and blood pressure in cirrhosis

1 reference

12 December 2020

Improvement of hepatic encephalopathy treated with flumazenil

1 reference

12 December 2020

Influence of hepatic dysfunction on the pharmacokinetics of propafenone.

1 reference

12 December 2020

Propoxyphene and norpropoxyphene plasma concentrations after oral propoxyphene in cirrhotic patients with and without surgically constructed portacaval shunt

1 reference

12 December 2020

Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor

1 reference

12 December 2020

Associations Between Risk Factors for Valproate Hepatotoxicity and Altered Valproate Metabolism

1 reference

12 December 2020

Effects of nifedipine on functional liver plasma flow in normal subjects and in patients with cirrhosis

1 reference

12 December 2020

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

12 December 2020

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

12 December 2020

Effects of sulindac and ibuprofen in patients with cirrhosis and ascites. An explanation for the renal-sparing effect of sulindac

1 reference

12 December 2020

The pharmacokinetics of perindopril in patients with liver cirrhosis

1 reference

12 December 2020

Isoniazid, rifampin, and hepatotoxicity

1 reference

12 December 2020

Possible deleterious hemodynamic effect of nifedipine on portal hypertension in patients with cirrhosis

1 reference

12 December 2020

The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment

1 reference

12 December 2020

Spironolactone and enzyme induction in patients with alcoholic cirrhosis

1 reference

12 December 2020

Captopril and resistant ascites

1 reference

12 December 2020

Antibiotic-associated hypoprothrombinemia: a review of prospective studies, 1966-1988.

1 reference

12 December 2020

Prediction of creatinine clearance from serum creatinine

1 reference

12 December 2020

Is there increased cerebral sensitivity to benzodiazepines in chronic liver disease?

1 reference

12 December 2020

Clinical toxicity of chloridazepoxide and diazepam in relation to serum albumin concentration: A report from the Boston collaborative drug surveillance Program

1 reference

12 December 2020

Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy subjects and in disease states

1 reference

12 December 2020

Biotransformation of amitriptyline in alcoholic depressive patients

1 reference

12 December 2020

Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with cirrhosis

1 reference

12 December 2020

Oral prednisone for chronic active liver disease: dose responses and bioavailability studies

1 reference

12 December 2020

Pharmacokinetics of temocapril, an ACE inhibitor with preferential biliary excretion, in patients with impaired liver function

1 reference

12 December 2020

The effects of age and chronic liver disease on the elimination of temazepam

1 reference

12 December 2020

Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis

1 reference

12 December 2020

Pharmacokinetics of diltiazem in patients with liver cirrhosis

1 reference

12 December 2020

Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment

1 reference

12 December 2020

Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes

1 reference

12 December 2020

Hepatic reactions during ketoconazole treatment

1 reference

12 December 2020

Naproxen disposition in patients with alcoholic cirrhosis

1 reference

12 December 2020

Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis

1 reference

12 December 2020

Interferon-mediated depression of cytochrome P-450-dependent drug biotransformation

1 reference

12 December 2020

Antidepressants and liver disease

1 reference

12 December 2020

The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacin

1 reference

12 December 2020

Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertension

1 reference

12 December 2020

Mechanism of the excessive sedative response of cirrhotics to benzodiazepines: model experiments with triazolam.

1 reference

12 December 2020

Adverse reactions to prolonged treatment with high doses of carbenicillin and ureidopenicillins

1 reference

12 December 2020

The pharmacokinetics of zidovudine administered by continuous infusion in children

1 reference

12 December 2020

Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites

1 reference

12 December 2020

Theophylline-induced seizures in adults. Correlation with serum concentrations

1 reference

12 December 2020

Nifedipine: kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration

1 reference

12 December 2020

Disposition of bupropion in healthy volunteers and subjects with alcoholic liver disease

1 reference

12 December 2020

Furosemide-induced adverse reactions in cirrhosis of the liver

1 reference

12 December 2020

Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides

1 reference

12 December 2020

Repeated diazepam dosing in cirrhotic patients: cumulation and sedation

1 reference

12 December 2020

The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease

1 reference

12 December 2020

The pharmacokinetics of Casodex enantiomers in subjects with impaired liver function

1 reference

12 December 2020

Pharmacokinetics of fluvoxamine maleate in patients with liver cirrhosis after single-dose oral administration

1 reference

12 December 2020

Disposition of valproic acid in patients with liver disease

1 reference

12 December 2020

Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance

1 reference

12 December 2020

Clinical pharmacokinetics in patients with liver disease

1 reference

12 December 2020

Captopril and resistant ascites: a word of caution

1 reference

12 December 2020

Pharmacokinetics of [14C]omeprazole in patients with liver cirrhosis

1 reference

12 December 2020

Pharmacokinetics of erythromycin in patients with severe cirrhosis. Respective influence of decreased serum binding and impaired liver metabolic capacity

1 reference

12 December 2020

Acetaminophen in chronic liver disease

1 reference

12 December 2020

Effects of hepatic function on vancomycin clinical pharmacology

1 reference

12 December 2020

Clinical pharmacokinetics of selective serotonin reuptake inhibitors

1 reference

12 December 2020

Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance

1 reference

12 December 2020

Pharmacokinetics of metronidazole in patients with alcoholic liver disease

1 reference

12 December 2020

Intravenous administration of diazepam in patients with chronic liver disease

1 reference

12 December 2020

Morphine tolerance in hepatic cirrhosis

1 reference

12 December 2020

Erythromycin ototoxicity and acute psychotic reaction in cancer patients with hepatic dysfunction

1 reference

12 December 2020

Ranitidine versus cimetidine. A comparison of their potential to cause clinically important drug interactions

1 reference

12 December 2020

Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis

1 reference

12 December 2020

Flumazenil disposition and elimination in cirrhosis

1 reference

12 December 2020

The effect of cimetidine on hepatic drug elimination in cirrhosis

1 reference

12 December 2020

Inhibition of human liver cytochrome P-450 by omeprazole

1 reference

12 December 2020

Angiotensin-converting enzyme (ACE)-inhibition in cirrhosis. Pharmacokinetics and dynamics of the ACE-inhibitor cilazapril (Ro 31-2848)

1 reference

12 December 2020

Effects of cirrhosis and ageing on the elimination and bioavailability of ranitidine

1 reference

12 December 2020

Resuscitation of hemorrhagic shock in cirrhotics taking propranolol

1 reference

12 December 2020

Theophylline disposition in patients with hepatic cirrhosis

1 reference

12 December 2020

Pharmacokinetics of Metoprolol in Patients with Hepatic Cirrhosis

1 reference

12 December 2020

Pharmacokinetics and ascitic fluid penetration of piperacillin in cirrhosis

1 reference

12 December 2020

A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993)

1 reference

12 December 2020

The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands

1 reference

12 December 2020

Elevated plasma nilvadipine concentration after single and chronic oral administration to patients with chronic liver disease

1 reference

12 December 2020

Clinical effects and metabolism of diazepam in patients with chronic liver disease.

1 reference

12 December 2020

Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril

1 reference

12 December 2020

Mental confusion in a patient treated with metronidazole--a concentration-related effect?

1 reference

12 December 2020

Disposition of diazepam and its major metabolite desmethyldiazepam in patients with liver disease

1 reference

12 December 2020

Age, disease, and cimetidine disposition in healthy subjects and chronically ill patients

1 reference

12 December 2020

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule

1 reference

12 December 2020

Effect of cirrhosis and renal failure on the kinetics of clotiazepam

1 reference

12 December 2020

The effect of hepatic cirrhosis on the pharmacokinetics and blood pressure response to nicardipine

1 reference

12 December 2020

Effect of cimetidine on microsomal drug metabolism in man

1 reference

12 December 2020

Risk factors for the development of auditory toxicity in patients receiving aminoglycosides

1 reference

12 December 2020

Undesirable side effects of isoniazid and rifampin in largely twice-weekly short-course chemotherapy for tuberculosis.

1 reference

12 December 2020

Hepatic encephalopathy: current status

1 reference

12 December 2020

Clinical pharmacokinetics of newer antibacterial agents in liver disease

1 reference

12 December 2020

Single-dose ceftriaxone kinetics in liver insufficiency

1 reference

12 December 2020

Renal syndromes associated with nonsteroidal antiinflammatory drugs

1 reference

12 December 2020

Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro.

1 reference

12 December 2020

A new method to assay des-gamma-carboxyprothrombin. Results obtained in 75 cases of hepatocellular carcinoma

1 reference

12 December 2020

Pharmacology of cefotaxime and its desacetyl metabolite in renal and hepatic disease

1 reference

12 December 2020

Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers

1 reference

12 December 2020

Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062).

1 reference

12 December 2020

Side effects of ranitidine

1 reference

12 December 2020

Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver diseases

1 reference

12 December 2020

Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial

1 reference

12 December 2020

Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease

1 reference

12 December 2020

10.2165/00002018-199717010-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

24 September 2017

1010874380

0 references

Fatcat ID

release_x4ecz4uiargkrb4mpnmdk3px54

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/x4ecz4uiargkrb4mpnmdk3px54

24 November 2022

mapped directly with Wikidata item

1 reference